captopril has been researched along with Diabetic Angiopathies in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (24.32) | 18.7374 |
| 1990's | 18 (48.65) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 1 (2.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alosh, M; Huque, MF | 1 |
| Deedwania, PC | 1 |
| Fisher, ND; Freeman, KD; Hollenberg, NK; Lansang, CM; Stevanovic, RD | 1 |
| Atkinson, AB; Bell, PM; Browne, J; Ennis, CN; Hunter, SJ; McLaughlin, DM; Sheridan, B | 1 |
| Jeandidier, N; Klewansky, M; Pinget, M | 1 |
| Bomanji, JB; Britton, KE; Datseris, IE; Nijran, KS; Nimmon, CC; Siraj, QH; Sonmezoglu, K | 1 |
| Bolli, GB; Britta, M; Brunetti, P; Perriello, G; Rambotti, AM; Santeusanio, F; Torlone, E | 1 |
| Lacourcière, Y; Nadeau, A; Poirier, L; Tancrède, G | 1 |
| Chakir, M; D'Orléans-Juste, P; Plante, GE | 1 |
| Donnelly, R; Molyneaux, LM; Willey, KA; Yue, DK | 1 |
| Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Solini, A | 1 |
| Phillips, PJ; Popplewell, PY; Tallis, GA | 1 |
| Alzahabi, B; Dunn, SR; Eltayeb, BO; Lewis, EJ; McGowan, TA; Rohde, R; Sharma, K; Ziyadeh, FN | 1 |
| Alderman, MH; Applegate, WB; Furberg, CD; Pahor, M; Psaty, BM; Williamson, JD | 1 |
| Bakir, S; Oparil, S | 1 |
| Bertrand, M; Boccara, G; Godet, G; Koskas, F; Van de Steen, E | 1 |
| Aiello, LP; Clermont, A; Feener, EP; Hata, Y; Pokras, F; Rook, SL; Suzuma, I; Suzuma, K | 1 |
| Hansson, L; Hedner, T; Lanke, J; Niklason, A; Niskanen, L | 1 |
| Liu, Z; Wang, J; Yang, S | 1 |
| Carruthers, SG | 1 |
| Studney, D | 1 |
| Anversa, P; Armstrong, PW; Brilla, CG; Burnett, JC; Cruickshank, JM; Devereux, RB; Giles, TD; Korsgaard, N; Leier, CV; Weber, KT | 1 |
| Andreani, D; Bacci, S; Di Mario, U; Morabito, S; Morano, S; Pierucci, A; Pietravalle, P; Pugliese, G; Simonetti, B | 1 |
| Kawai, K; Murayama, Y; Suzuki, S; Watanabe, Y; Yamashita, K | 1 |
| Antonini, P; Beretta-Piccoli, C; Bernasconi-Zapf, M; Kressebuch, H; Pianezzi, F; Ziegler, WH | 1 |
| Christov, V; Nikolov, M; Nikolov, N; Popova, D; Suzuki, A | 1 |
| Leone, S; Scapellato, L; Stornello, M; Valvo, EV; Vasques, E | 1 |
| Leblanc, H; Marre, M; Passa, P | 1 |
| Dineen, M; Kelleher, M; Sullivan, PA; Twomey, M | 1 |
| Balsano, F; De Mattia, G; Ferri, C; Laurenti, O; Tullo, G; Ventura, C; Ziantoni, R | 1 |
| Aguilar, M; Campos-Pastor, MM; Escobar-Jiminez, F; Fernandez Soto, ML; Garcia del Rio, C; Lobon, JA | 1 |
| Dietze, G; Mehnert, H; Rett, K; Tschollar, W; Wicklmayr, M | 1 |
| Caralps, A; Foz, M; Romero, R; Salinas, I; Sanmartí, A; Teixidó, J | 1 |
| Bennett, T; Gardiner, SM; Hebden, RA | 1 |
6 review(s) available for captopril and Diabetic Angiopathies
| Article | Year |
|---|---|
Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetic Angiopathies; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Sodium Chloride Symporter Inhibitors | 2005 |
Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Cross-Over Studies; Diabetic Angiopathies; Diabetic Nephropathies; Diuretics; Humans; Hypertension; Indapamide | 1996 |
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Randomized Controlled Trials as Topic | 2000 |
The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension | 2001 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
Remodeling and reparation of the cardiovascular system.
Topics: Animals; Blood Pressure; Captopril; Cardiomegaly; Collagen; Coronary Circulation; Diabetic Angiopathies; Endothelins; Endothelium, Vascular; Fibrosis; Heart; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Muscle, Smooth, Vascular; Myocardium; Peptidyl-Dipeptidase A; Rats; Vascular Resistance | 1992 |
16 trial(s) available for captopril and Diabetic Angiopathies
| Article | Year |
|---|---|
Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Glucose Clamp Technique; Humans; Hypertension; Insulin; Insulin Resistance; Middle Aged; Treatment Outcome | 2008 |
Hypertension in Diabetes Study. III. Prospective study of therapy of hypertension in type 2 diabetic patients: efficacy of ACE inhibition and beta-blockade.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Triglycerides; United Kingdom | 1994 |
Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
Topics: Aged; Analysis of Variance; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Lipid Metabolism; Male; Middle Aged | 1993 |
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
Topics: Aged; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Metoprolol; Middle Aged; Prospective Studies | 1993 |
Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Cross-Over Studies; Diabetic Angiopathies; Diabetic Nephropathies; Diuretics; Humans; Hypertension; Indapamide | 1996 |
Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
Topics: Adult; Antihypertensive Agents; Antiporters; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Erythrocytes; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Lithium; Male; Middle Aged; Nifedipine; Sodium; Sodium-Hydrogen Exchangers; Triglycerides | 1997 |
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Proteinuria; Visual Acuity; Weight Gain | 1998 |
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome; Visual Acuity; Weight Gain | 1998 |
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension, Renal; Kidney Function Tests; Male; Transforming Growth Factor beta | 1999 |
Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Captopril; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetic Angiopathies; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk; Stroke | 2001 |
[Clinical effect of captopril in diabetic patients with complicated acute myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Treatment Outcome | 1999 |
Selective decrement of anionic immunoglobulin clearance after induced renal hemodynamic changes in diabetic patients.
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Captopril; Clonidine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemodynamics; Humans; Hypertension; Immunoglobulin G; Male; Middle Aged; Proteinuria; Renal Circulation; Vascular Resistance | 1992 |
Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.
Topics: Analysis of Variance; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Pulse | 1992 |
Captopril does not alter metabolic control in elderly hypertensive diabetics during secondary failure.
Topics: Aged; Blood Glucose; Blood Pressure; C-Peptide; Captopril; Clinical Trials as Topic; Diabetic Angiopathies; Drug Therapy, Combination; Fructosamine; Hexosamines; Humans; Hypertension; Insulin; Middle Aged | 1988 |
Effect of captopril at two different dosage regimens in hypertensive non-insulin dependent patients.
Topics: Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1988 |
Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Middle Aged; Random Allocation | 1988 |
16 other study(ies) available for captopril and Diabetic Angiopathies
| Article | Year |
|---|---|
A consistency-adjusted alpha-adaptive strategy for sequential testing.
Topics: Algorithms; Biostatistics; Captopril; Clinical Trials as Topic; Data Interpretation, Statistical; Diabetic Angiopathies; Endpoint Determination; Epidemiologic Research Design; Heart Failure; Humans; Losartan; Pioglitazone; Randomized Controlled Trials as Topic; Thiazolidinediones | 2010 |
Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
Topics: Antihypertensive Agents; Blood Glucose; Captopril; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gastroparesis; Homeostasis; Humans; Hyperlipidemias; Hypertension; Renin; Sodium, Dietary; Thyroid Diseases | 2007 |
Captopril-induced acute pancreatitis.
Topics: Abdominal Pain; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pancreatitis | 1995 |
Predictive value of captopril transit renography in essential hypertension and diabetic nephropathy.
Topics: Adult; Aged; Captopril; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Radioisotope Renography; Renal Artery Obstruction; Technetium Tc 99m Mertiatide | 1995 |
Neutral endopeptidase inhibition, a new approach in the exploration of diabetic vasculopathy in rats.
Topics: Alanine; Animals; Blood Pressure; Capillary Permeability; Captopril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Female; Glycopeptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Streptozocin; Thiorphan | 1995 |
The diabetic with renal impairment.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Coma; Diabetic Nephropathies; Humans; Hypertension; Male | 1997 |
Recent outcome trials of newer antihypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetic Angiopathies; Humans; Hypertension; Treatment Outcome | 1999 |
[Thrombopenia increased by heparin and danaparoid].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Captopril; Carotid Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Hypertension; Stroke; Thrombocytopenia | 2001 |
Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Cattle; Cells, Cultured; Diabetic Angiopathies; Diabetic Retinopathy; Endothelium, Vascular; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinal Vessels; RNA, Messenger; Stress, Mechanical; Tetrazoles | 2001 |
Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetic Angiopathies; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Renin; Sodium; Time Factors | 1990 |
Captopril in treatment of hypertensive diabetic patients. Preliminary study.
Topics: Captopril; Diabetic Angiopathies; Female; Humans; Hypertension; Male; Middle Aged | 1989 |
Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Kidney; Male; Middle Aged | 1989 |
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Enalapril; Humans; Hypertension; Obesity; Vasodilator Agents | 1985 |
Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetic Angiopathies; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Posture; Renin | 1985 |
[Usefulness of angiotensin converting enzyme inhibitors in the treatment of diabetic nephropathy].
Topics: Adult; Aged; Captopril; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies | 1988 |
Abnormal blood pressure recovery during ganglion blockade in diabetic rats.
Topics: Animals; Blood Pressure; Captopril; Deamino Arginine Vasopressin; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Heart Rate; Insulin; Male; Pentolinium Tartrate; Rats; Rats, Inbred Strains | 1987 |